XML 29 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Other Balance Sheet Components
 3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Other Balance Sheet Components Other Balance Sheet Components
Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets, as of March 31, 2023 and December 31, 2022 consisted of the following (in millions):
March 31,December 31,
20232022
Prepaid services$292 $216 
Down payments for materials and supplies219 219 
Value added tax receivable201 140 
Prepaid income taxes187 187 
Down payments to manufacturing vendors184 229 
Income tax receivable96 10 
Interest receivable69 61 
Tenant improvement allowance receivable42 42 
Convertible note receivable— 36 
Other current assets64 55 
Prepaid expenses and other current assets$1,354 $1,195 

Other Non-Current Assets

Other non-current assets, as of March 31, 2023 and December 31, 2022 consisted of the following (in millions):
March 31,December 31,
20232022
Inventory, non-current(1)
$874 $910 
Equity investments83 42 
Finite-lived intangible asset (Note 6)
48 — 
Goodwill (Note 6)
52 — 
Restricted cash20 12 
Other87 24 
Other non-current assets$1,164 $988 
_______
(1) Consisted of raw materials with an anticipated consumption beyond one year.
Accrued Liabilities

Accrued liabilities, as of March 31, 2023 and December 31, 2022 consisted of the following (in millions):
March 31,December 31,
20232022
Manufacturing$397 $400 
Other external goods and services313 264 
Clinical trials263 319 
Loss on future firm purchase commitments(1)
220 268 
Development operations98 88 
Royalties86 203 
Compensation-related73 190 
Raw materials58 316 
Property and equipment58 5 
Other47 48 
Accrued liabilities$1,613 $2,101 
______
(1) Related to losses that are expected to arise from firm, non-cancellable, commitments for future raw material purchases (Note 9).

Other Current Liabilities

Other current liabilities, as of March 31, 2023 and December 31, 2022 consisted of the following (in millions):
March 31,December 31,
20232022
Lease liabilities - financing (Note 12)
$153 $161 
Lease liabilities - operating (Note 12)
28 35 
Other31 53 
Other current liabilities$212 $249 

Deferred Revenue

The following table summarizes the activities in deferred revenue for the three months ended March 31, 2023 (in millions):
December 31, 2022AdditionsDeductionsMarch 31, 2023
Product sales$2,626 $45 $(855)$1,816 
Grant revenue4 — (1)3 
Collaboration revenue81 2 (10)73 
Total deferred revenue$2,711 $47 $(866)$1,892